The Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP), managed by the office of Congressionally Directed Medical Research Programs (CDMRP) has recently released the following funding opportunity information.
The Peer Reviewed Medical Program (PRMRP) supports research across a broad range of health care science and medicine topics and across a wide range of disciplines including cardiovascular and endocrine health, autoimmune diseases and immunology, infectious diseases, internal medicine, neurological and psychological health, orthopedic and regenerative medicine, and respiratory and environmental health and injury. The PRMRP mission is to “Encourage, identify, select, and manage medical research projects of clear scientific merit and direct relevance to military health”. A key feature of the PRMRP is relevance to military health. A list of websites that may be useful in identifying additional information about ongoing DoD and VA areas of research interest or potential opportunities for collaboration within the FY19 PRMRP Topic Areas can be found in the Appendix section of each program announcement solicitation.
Deadlines: Pre-applications are due in March and Applications are due in July except for the Discovery Award Application which is due in April.
Current open PRMP Award Mechanisms and Program Announcements are listed here and include the following:
· Discovery Award – (up to $200,000) to support innovative, non-incremental, high-risk/potentially high-reward research; preliminary data not required but allowed.
· Clinical Trail Award – (approx. $58.5M to fund approx. 9 Clinical Trial Awards) proposed projects may range from small proof-of-concept through large-scale trials.
· Focused Program Award – (approximately $43.2M to fund approximately 4 Focused Program Award applications) to support a unifying overarching challenge that will be addressed by a set of distinct research projects; a minimum of four projects are strongly encouraged and additional studies are allowed.
· Investigator-Initiated Research Award – (approximately $79.6M to fund approximately 42 Investigator-Initiated Research Awards) projects may focus on any phase of research from basic laboratory research through translational research and must include relevant data that support the rationale for the proposed study.
· Technology/Therapeutic Development Award – (approximately $72M to fund approximately 16 Technology/Therapeutic Development Award applications) a product-driven award mechanism to provide support for the translation of promising preclinical findings into products for clinical applications.
- Acute Lung Injury
- Antimicrobial Resistance
- Arthritis
- Burn Pit Exposure
- Cardiomyopathy
- Cerebellar Ataxia
- Chronic Migraine and Post-Traumatic Headache
- Congenital Heart Disease
- Constrictive Bronchiolitis
- Diabetes
- Dystonia
- Eating Disorders
- Emerging Infectious Diseases
- Epidermolysis Bullosa
- Focal Segmental Glomerulosclerosis
- Frontotemporal Degeneration
- Guillain-Barre Syndrome
- Hemorrhage Control
- Hepatitis B
- Hereditary Angioedema
- Hydrocephalus
- Immunomonitoring of Intestinal Transplants
- Inflammatory Bowel Diseases
- Interstitial Cystitis
- Lung Injury
- Metals Toxicology
- Mitochondrial Disease
- Musculoskeletal Disorders
- Myotonic Dystrophy
- Nanomaterials for Bone Regeneration
- Nutrition Optimization
- Pancreatitis
- Pathogen-Inactivated Blood Products
- Polycystic Kidney Disease
- Post-Traumatic Osteoarthritis
- Pressure Ulcers
- Pulmonary Fibrosis
- Resilience Training
- Respiratory Health
- Rett Syndrome
- Rheumatoid Arthritis
- Scleroderma
- Sleep Disorders
- Spinal Muscular Atrophy
- Tinnitus
- Tissue Regeneration
- Tuberculosis
- Vascular Malformations
- Women's Heart Disease
Posts
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.